IRIS
DI MARIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.779
AS - Asia 13.287
EU - Europa 13.236
SA - Sud America 862
AF - Africa 237
Continente sconosciuto - Info sul continente non disponibili 63
OC - Oceania 49
Totale 49.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.422
CN - Cina 6.324
SG - Singapore 4.956
IE - Irlanda 3.621
SE - Svezia 3.249
TR - Turchia 1.443
UA - Ucraina 1.209
FI - Finlandia 1.092
DE - Germania 968
NL - Olanda 923
IT - Italia 799
BR - Brasile 774
RU - Federazione Russa 486
CA - Canada 321
GB - Regno Unito 313
CI - Costa d'Avorio 171
BE - Belgio 144
IN - India 125
HK - Hong Kong 80
AT - Austria 79
FR - Francia 68
EU - Europa 59
RO - Romania 47
AU - Australia 46
IR - Iran 38
ID - Indonesia 36
LT - Lituania 36
CZ - Repubblica Ceca 33
HU - Ungheria 27
UZ - Uzbekistan 23
JP - Giappone 22
PK - Pakistan 22
IL - Israele 21
AR - Argentina 20
IQ - Iraq 20
KR - Corea 20
BD - Bangladesh 18
EC - Ecuador 18
PL - Polonia 18
AE - Emirati Arabi Uniti 16
MA - Marocco 15
BG - Bulgaria 14
EG - Egitto 14
ES - Italia 14
CO - Colombia 13
KG - Kirghizistan 13
VN - Vietnam 13
SK - Slovacchia (Repubblica Slovacca) 12
VE - Venezuela 12
CL - Cile 11
PH - Filippine 11
CH - Svizzera 10
PT - Portogallo 10
AZ - Azerbaigian 9
HR - Croazia 9
MX - Messico 9
LV - Lettonia 8
PA - Panama 8
TN - Tunisia 8
GR - Grecia 7
KE - Kenya 7
LK - Sri Lanka 7
TW - Taiwan 7
ZA - Sudafrica 7
JM - Giamaica 6
KZ - Kazakistan 6
NP - Nepal 6
RS - Serbia 6
BO - Bolivia 5
DZ - Algeria 5
EE - Estonia 5
GE - Georgia 5
KH - Cambogia 5
LU - Lussemburgo 5
MD - Moldavia 5
NO - Norvegia 5
PE - Perù 5
AL - Albania 4
AM - Armenia 4
CR - Costa Rica 4
DK - Danimarca 4
LB - Libano 4
OM - Oman 4
SA - Arabia Saudita 4
XK - ???statistics.table.value.countryCode.XK??? 4
BY - Bielorussia 3
CY - Cipro 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SN - Senegal 3
TH - Thailandia 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
JO - Giordania 2
LY - Libia 2
NG - Nigeria 2
SV - El Salvador 2
TJ - Tagikistan 2
Totale 49.494
Salva come PNG Salva come JPEG
Città #
Chandler 4.808
Dublin 3.613
Singapore 2.688
Santa Clara 2.073
Dearborn 1.619
Ashburn 1.357
Nanjing 1.310
Izmir 1.236
Beijing 1.230
Jacksonville 1.222
Boardman 1.012
Princeton 831
Shanghai 483
Wilmington 464
San Mateo 446
New York 431
Moscow 428
Helsinki 415
Ann Arbor 399
Shenyang 372
Nanchang 353
Hebei 297
Toronto 261
Kunming 241
Jinan 217
Changsha 205
Tianjin 202
Jiaxing 198
Hefei 182
Kocaeli 174
Parma 168
Abidjan 165
Los Angeles 151
Munich 144
Brussels 131
Norwalk 131
Seattle 108
Hangzhou 106
Guangzhou 102
Fremont 92
Pune 86
Zhengzhou 81
Des Moines 72
Bremen 70
Hong Kong 68
Chicago 64
Ningbo 64
Vienna 61
São Paulo 52
London 51
Council Bluffs 49
Dallas 49
Frankfurt am Main 49
Woodbridge 48
Milan 47
Houston 45
Washington 43
Grafing 38
Nuremberg 37
Taizhou 36
Edinburgh 34
Haikou 32
Lanzhou 32
Wuhan 29
Cambridge 28
Borås 27
Melbourne 27
Taiyuan 27
Bologna 26
Chengdu 26
Fuzhou 25
Shaoxing 25
Rockville 24
Ottawa 23
Budapest 22
Leawood 22
Tashkent 22
Rome 20
Timisoara 20
Xian 20
Chongqing 19
Phoenix 19
Belo Horizonte 18
Rio de Janeiro 18
Andover 17
Redmond 17
The Dalles 17
Padova 16
Stockholm 16
Campinas 15
Changchun 15
Newark 15
Porto Alegre 15
Augusta 14
Bishkek 13
Dubai 13
Islington 13
Rio Saliceto 13
Sofia 13
Brasília 12
Totale 31.994
Salva come PNG Salva come JPEG
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 212
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 136
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 135
Approach to gastroenterological diseases in primary care 114
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 110
Thyroid and celiac disease in pediatric age: a literature review 108
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 108
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 105
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 105
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 103
How and when investigating and treating Helicobacter pylori infection in children 101
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 101
Gastric and duodenal ulcer in the same patient 100
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study 99
Long-term treatment for gastric and duodenal ulcer 99
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 98
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 98
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 96
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 96
Individualized treatment of duodenal ulcer disease. A pilot study 96
Burning Mouth Syndrome Etiology: A Narrative Review 95
Association of keratin 8 gene mutation with chronic pancreatitis 93
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy 93
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 93
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 92
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 92
Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H pylori infection? 91
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 90
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 89
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 89
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 89
Advanced gastric cancer: the value of surgery 89
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 89
Conservative treatment of acute appendicitis 89
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 89
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 89
Is it possible to withdrawal PPI’s therapy in GERD patients? A prospective study on 216 patients using HYCHSA 88
Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety 88
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 87
THE SLEEPING REMNANT 87
Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia 87
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 87
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 87
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 87
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 86
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 86
Treatment of Helicobacter pylori infection. 86
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 86
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 86
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 86
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 86
Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance 86
Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study 85
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 85
Autoimmune diseases in autoimmune atrophic gastritis 85
Follow-up in gastric dysplasia patients 85
Acid-related disorders in the elderly 84
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon 84
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 84
PPIs plus H2-antagonists for non-responders GERD patients: A rescue therapy? (a three months pilot study) 84
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 84
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 84
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 84
Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology 84
Efficacy of 5-ASA in the treatment of colonic diverticular disease 84
Efficacy of one-week triple therapies with low-dose rabeprazole and clarithromycin plus standard-dose amoxicillin or tinidazole for the cure of H pylori infection in elderly patients 83
Keratin 8 mutations in patients with chronic pancreatitis 83
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 83
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 83
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 83
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 83
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 83
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 83
Chronic atrophic gastritis (CAG) and Helicobacter pylori infection eradication: A 3 years follow-up 83
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 83
Reply 82
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 82
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. 82
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 82
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 82
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 82
Are tryptase and cathepsin D related to Helicobacter pylori infection and mucosal gastrin in peptic ulcer? 82
Effects of gastroesophageal reflux disease in laryngeal carcinoma 81
Helicobacter pylori non-cytotoxic genotipe enhances mucosal gastrin and MAST cell triptase 81
Prevalence of intestinal metaplasia in the distal oesophagus, oesophagogastric junction and gastric cardia in symptomatic patients in north-east Italy: a prospective, descriptive survey 81
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 81
Does chronic hypercalcemia influence serum pepsinogens levels? 81
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 81
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 81
Accuracy of urea breath tests tablets after 10 minutes compared with standard 30 minutes to diagnose and monitoring helicobacter pylori infection: A randomized controlled trial 81
Epidemiology and risk factors of pancreatic cancer 81
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 81
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 81
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 81
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 80
La Biopsie biochimica gastrica 80
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 80
Gastric epithelial dysplasia in the natural history of gastric cancer: A multicenter prospective follow-up study 80
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study) 80
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 80
Totale 9.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.249 0 0 0 0 0 0 0 0 0 789 173 287
2020/20212.322 47 278 272 18 295 49 260 11 431 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202314.711 1.540 1.337 984 1.304 1.153 1.798 103 1.127 4.622 60 555 128
2023/20244.820 251 577 136 136 414 1.364 214 351 145 282 398 552
2024/202511.992 347 988 1.140 853 1.997 1.879 504 660 2.511 1.113 0 0
Totale 50.243